Huang, Y.-M.; Cheng, C.-H.; Pan, S.-L.; Yang, P.-M.; Lin, D.-Y.; Lee, K.-H.
Gene Expression Signature-Based Approach Identifies Antifungal Drug Ciclopirox As a Novel Inhibitor of HMGA2 in Colorectal Cancer. Biomolecules 2019, 9, 688.
https://doi.org/10.3390/biom9110688
AMA Style
Huang Y-M, Cheng C-H, Pan S-L, Yang P-M, Lin D-Y, Lee K-H.
Gene Expression Signature-Based Approach Identifies Antifungal Drug Ciclopirox As a Novel Inhibitor of HMGA2 in Colorectal Cancer. Biomolecules. 2019; 9(11):688.
https://doi.org/10.3390/biom9110688
Chicago/Turabian Style
Huang, Yu-Min, Chia-Hsiung Cheng, Shiow-Lin Pan, Pei-Ming Yang, Ding-Yen Lin, and Kuen-Haur Lee.
2019. "Gene Expression Signature-Based Approach Identifies Antifungal Drug Ciclopirox As a Novel Inhibitor of HMGA2 in Colorectal Cancer" Biomolecules 9, no. 11: 688.
https://doi.org/10.3390/biom9110688
APA Style
Huang, Y.-M., Cheng, C.-H., Pan, S.-L., Yang, P.-M., Lin, D.-Y., & Lee, K.-H.
(2019). Gene Expression Signature-Based Approach Identifies Antifungal Drug Ciclopirox As a Novel Inhibitor of HMGA2 in Colorectal Cancer. Biomolecules, 9(11), 688.
https://doi.org/10.3390/biom9110688